Medline Secures Prime Vendor Agreement with Allina Health
Tom Rudovsky · Reported by Reuters
More coverage: Medical Instrument Stocks · Healthcare
Sentiment
Positive
Importance
7
Price
$40.51
Mkt Cap
$53.218B
52W Low
$32.815
52W High
$50.876
52W Position
23% above low
Off High
20% below high
Rel. Volume
0.6× avg
Market data snapshot near publication time
MDLN sits 23% above its 52-week low of $32.815.
Summary
Medline secured a prime vendor agreement with Allina Health, positioning itself as the primary supplier for the health system. This deal is a positive operational win, strengthening Medline's market position and securing future revenue streams. For a company of Medline's size, this is a solid business development, though the specific financial impact is not disclosed.
At the time of this announcement, MDLN was trading at $40.51 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $53.2B. The 52-week trading range was $32.82 to $50.88. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.
Price Chart
MDLN - Latest Insights
MDLN
Aug 13, 2026, 2:00 PM EDT
Price at Filing:
$36.08
Real-time Price:
$34.30
Change:
-$1.78 (-5%)
Market Cap:
$45.62B
MDLN
Aug 05, 2026, 7:42 AM EDT
Price at Filing:
$38.00
Real-time Price:
$34.30
Change:
-$3.70 (-10%)
Market Cap:
$45.62B
MDLN
Aug 05, 2026, 7:34 AM EDT
Price at Filing:
$38.00
Real-time Price:
$34.30
Change:
-$3.70 (-10%)
Market Cap:
$45.62B
MDLN
Jul 09, 2026, 4:00 PM EDT
Price at Filing:
$40.85
Real-time Price:
$34.30
Change:
-$6.55 (-16%)
Market Cap:
$45.62B
MDLN
Jul 02, 2026, 9:00 AM EDT
Price at Filing:
$41.73
Real-time Price:
$34.30
Change:
-$7.43 (-18%)
Market Cap:
$45.62B